MD, PhDDeborahHallDeborah A. Hall41.87340050000000-87.67011710000000349034Hall, DeborahA.My Scopus ID is 26321484200.
My NIH COMMONS name is HALL.D.312-563-2900Associate Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifierbibo:suffixNamename suffixAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:middleNamemiddle name or initialvivo:overviewoverviewvivo:personInPositionpositionsvivo:phoneNumberphonePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 32561830065951Vittal P, Pandya S, Sharp K, Berry-Kravis E, Zhou L, Ouyang B, Jackson J, Hall DANeurology. GeneticsASFMR1 splice variant: A predictor of fragile X-associated tremor/ataxia syndrome. Neurol Genet. 2018 Aug; 4(4):e246.Neurol Genet2018-07-27T00:00:002018ASFMR1 splice variant: A predictor of fragile X-associated tremor/ataxia syndrome.D005600Disorders151890.797394Fragile X SyndromeAuthorship 329971030243213O'Keefe JA, Robertson EE, Ouyang B, Carns D, McAsey A, Liu Y, Swanson M, Bernard B, Berry-Kravis E, Hall DAGait & postureCognitive function impacts gait, functional mobility and falls in fragile X-associated tremor/ataxia syndrome. Gait Posture. 2018 10; 66:288-293.Gait Posture2018-09-12T00:00:002018Cognitive function impacts gait, functional mobility and falls in fragile X-associated tremor/ataxia syndrome.Authorship 337931Authorship 338031Authorship 33805130363360Hall DA, Hermanson M, Dunn E, Stebbins G, Merkitch D, Ouyang B, Berry-Kravis E, Jhaveri MMovement disorders clinical practiceThe Corpus Callosum Splenium Sign in Fragile X-Associated Tremor Ataxia Syndrome. Mov Disord Clin Pract. 2017 May-Jun; 4(3):383-388.Mov Disord Clin Pract2016-11-16T00:00:002016The Corpus Callosum Splenium Sign in Fragile X-Associated Tremor Ataxia Syndrome.30363575Hall DA, Stebbins GT, Litvan I, Bordelon Y, Riley DE, Leverenz J, Standaert DGMovement disorders clinical practiceClinimetric Analysis of the Motor Section of the Progressive Supranuclear Palsy Rating Scale: Reliability and Factor Analysis. Mov Disord Clin Pract. 2016 Jan-Feb; 3(1):65-67.Mov Disord Clin Pract2015-10-20T00:00:002015Clinimetric Analysis of the Motor Section of the Progressive Supranuclear Palsy Rating Scale: Reliability and Factor Analysis.30363842Hall DA, Forjaz MJ, Golbe LI, Litvan I, Payan CAM, Goetz CG, Leentjens AFG, Martinez-Martin P, Traon AP, Sampaio C, Post B, Stebbins G, Weintraub D, Schrag AMovement disorders clinical practiceScales to Assess Clinical Features of Progressive Supranuclear Palsy: MDS Task Force Report. Mov Disord Clin Pract. 2015 Jun; 2(2):127-134.Mov Disord Clin Pract2015-05-22T00:00:002015Scales to Assess Clinical Features of Progressive Supranuclear Palsy: MDS Task Force Report.Authorship 340011Authorship 340039Authorship 34044130415919Garg RK, Ouyang B, Pandya V, Garcia-Cano R, Da Silva I, Hall D, John S, Bleck TP, Berkelhammer MJournal of stroke and cerebrovascular diseases : the official journal of National Stroke AssociationThe Influence of Weather on the Incidence of Primary Spontaneous Intracerebral Hemorrhage. J Stroke Cerebrovasc Dis. 2019 Feb; 28(2):405-411.J Stroke Cerebrovasc Dis2018-11-08T00:00:002018The Influence of Weather on the Incidence of Primary Spontaneous Intracerebral Hemorrhage.30428907Hall DA, Moore C, Comella CTrialsRecruitment of patients with de novo Parkinson disease: successful strategies in a randomized exercise clinical trial. Trials. 2018 Nov 14; 19(1):630.Trials2018-11-14T00:00:002018Recruitment of patients with de novo Parkinson disease: successful strategies in a randomized exercise clinical trial.30455257Hall DANeurologyAuthor response: The state of clinical research in neurology. Neurology. 2018 11 20; 91(21):984.Neurology2018-11-20T00:00:002018Author response: The state of clinical research in neurology.28835261Fackrell K, Smith H, Colley V, Thacker B, Horobin A, Haider HF, Londero A, Mazurek B, Hall DATrialsCore Outcome Domains for early phase clinical trials of sound-, psychology-, and pharmacology-based interventions to manage chronic subjective tinnitus in adults: the COMIT'ID study protocol for using a Delphi process and face-to-face meetings to establish consensus. Trials. 2017 08 23; 18(1):388.Trials2017-08-23T00:00:002017Core Outcome Domains for early phase clinical trials of sound-, psychology-, and pharmacology-based interventions to manage chronic subjective tinnitus in adults: the COMIT'ID study protocol for using a Delphi process and face-to-face meetings to establish consensus.Authorship 347384Authorship 348756Authorship 348941Authorship 34922230363594Pal G, Robertson E, O'Keefe J, Hall DMovement disorders clinical practiceThe Neuropsychiatric and Motor Profile of GBA-Associated Parkinson's Disease: A Review. Mov Disord Clin Pract. 2016 Jan-Feb; 3(1):4-8.Mov Disord Clin Pract2015-09-16T00:00:002015The Neuropsychiatric and Motor Profile of GBA-Associated Parkinson's Disease: A Review.30713915Vittal P, Hall DA, Dames S, Mao R, Berry-Kravis EMovement disorders clinical practiceBCAP31 Mutation Causing a Syndrome of Congenital Dystonia, Facial Dysorphism and Central Hypomyelination Discovered Using Exome Sequencing. Mov Disord Clin Pract. 2016 Mar-Apr; 3(2):197-199.Mov Disord Clin Pract2015-10-28T00:00:002015BCAP31 Mutation Causing a Syndrome of Congenital Dystonia, Facial Dysorphism and Central Hypomyelination Discovered Using Exome Sequencing.30838310Hall DA, Stebbins GT, Jacquemont S, Berry-Kravis E, Goetz CG, Hagerman R, Zhang L, Leehey MAMovement disorders clinical practiceClinimetric Properties of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale. Mov Disord Clin Pract. 2019 Feb; 6(2):120-124.Mov Disord Clin Pract2019-01-22T00:00:002019Clinimetric Properties of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale.Authorship 35371631010765Garg RK, Ouyang B, Pandya V, Garcia-Cano R, Da Silva I, Hall D, John S, Bleck TP, Berkelhammer MJournal of stroke and cerebrovascular diseases : the official journal of National Stroke AssociationAuthors' Response to "Barometric Pressure in Cerebral Amyloid Angiopathy: A Pressure to Bleed?" J Stroke Cerebrovasc Dis. 2019 06; 28(6):1782.J Stroke Cerebrovasc Dis2019-04-20T00:00:002019Authors' Response to "Barometric Pressure in Cerebral Amyloid Angiopathy: A Pressure to Bleed?"Authorship 35608531143438Fraint A, Ouyang B, Metman LV, Jones C, Hall DA, Marder K, Pal GParkinson's diseasePatient Knowledge and Attitudes towards Genetic Testing in Parkinson's Disease Subjects with Deep Brain Stimulation. Parkinsons Dis. 2019; 2019:3494609.Parkinsons Dis2019-04-21T00:00:002019Patient Knowledge and Attitudes towards Genetic Testing in Parkinson's Disease Subjects with Deep Brain Stimulation.true1ProfessorProfessor25763861O'Keefe JA, Robertson-Dick E, Dunn EJ, Li Y, Deng Y, Fiutko AN, Berry-Kravis E, Hall DACerebellum (London, England)Characterization and Early Detection of Balance Deficits in Fragile X Premutation Carriers With and Without Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS). Cerebellum. 2015 Dec; 14(6):650-62.Cerebellum2015-12-01T00:00:002015Characterization and Early Detection of Balance Deficits in Fragile X Premutation Carriers With and Without Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS).24958193Hall DA, Bennett DA, Filley CM, Shah RC, Kluger B, Ouyang B, Berry-Kravis ENeurobiology of agingFragile X gene expansions are not associated with dementia. Neurobiol Aging. 2014 Nov; 35(11):2637-2638.Neurobiol Aging2014-05-02T00:00:002014Fragile X gene expansions are not associated with dementia.Authorship 369266Authorship 37023831420308Rabadia SV, Litvan I, Juncos J, Bordelon Y, Riley DE, Standaert D, Reich SG, Hall DA, Kluger B, Shprecher D, Marras C, Jankovic JParkinsonism & related disordersHypertension and progressive supranuclear palsy. Parkinsonism Relat Disord. 2019 09; 66:166-170.Parkinsonism Relat Disord2019-08-03T00:00:002019Hypertension and progressive supranuclear palsy.31445159Dutta D, Kundu M, Mondal S, Roy A, Ruehl S, Hall DA, Pahan KNeurobiology of diseaseRANTES-induced invasion of Th17 cells into substantia nigra potentiates dopaminergic cell loss in MPTP mouse model of Parkinson's disease. Neurobiol Dis. 2019 12; 132:104575.Neurobiol Dis2019-08-22T00:00:002019RANTES-induced invasion of Th17 cells into substantia nigra potentiates dopaminergic cell loss in MPTP mouse model of Parkinson's disease.Authorship 37417931665686Shoeibi A, Litvan I, Juncos JL, Bordelon Y, Riley D, Standaert D, Reich SG, Shprecher D, Hall D, Marras C, Kluger B, Olfati N, Jankovic JParkinsonism & related disordersAre the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes? Parkinsonism Relat Disord. 2019 12; 69:34-39.Parkinsonism Relat Disord2019-10-14T00:00:002019Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?D001259Disorders14790.914708Ataxia1725 W. Harrison St.Chicago60612IL11139selected publications8.314050.0119609348research areas6.371130.030364334coauthor of414.98721.79960similar toAuthorship 29671Authorship 31161Authorship 31481Authorship 35581Authorship 29761Authorship 30521Authorship 33485Authorship 34376Authorship 32832Authorship 34771Authorship 30312Authorship 32182Authorship 32391Authorship 35661Authorship 34101Authorship 30174Authorship 30612Authorship 35073Authorship 34668Authorship 34121Authorship 28904Authorship 30191Authorship 34551Authorship 28941Authorship 32162Authorship 31617Authorship 33731Authorship 33455Authorship 32196Authorship 31541Authorship 354611Authorship 29868Authorship 28482Authorship 304212Authorship 29844Authorship 29971Authorship 35691Authorship 31352Authorship 33387Authorship 32021Authorship 31831Authorship 30282Authorship 33231Authorship 33913Authorship 35273Authorship 35495Authorship 293310Authorship 35832Authorship 358010Authorship 31064Authorship 3377422822237Schenkman M, Hall DA, Bar?n AE, Schwartz RS, Mettler P, Kohrt WMPhysical therapyExercise for people in early- or mid-stage Parkinson disease: a 16-month randomized controlled trial. Phys Ther. 2012 Nov; 92(11):1395-410.Phys Ther2012-07-19T00:00:002012Exercise for people in early- or mid-stage Parkinson disease: a 16-month randomized controlled trial.20222136Madden MB, Hall DAMovement disorders : official journal of the Movement Disorder SocietyShoulder pain in Parkinson's disease: a case-control study. Mov Disord. 2010 Jun 15; 25(8):1105-6.Mov Disord2010-06-15T00:00:002010Shoulder pain in Parkinson's disease: a case-control study.16970888Hall DA, Wadwa RP, Goldenberg NA, Norris JMJournal of child neurologyMaternal risk factors for term neonatal seizures: population-based study in Colorado, 1989-2003. J Child Neurol. 2006 Sep; 21(9):795-8.J Child Neurol2006-09-01T00:00:002006Maternal risk factors for term neonatal seizures: population-based study in Colorado, 1989-2003.24932424Hall DATremor and other hyperkinetic movements (New York, N.Y.)In the Gray Zone in the Fragile X Gene: What are the Key Unanswered Clinical and Biological Questions? Tremor Other Hyperkinet Mov (N Y). 2014; 4:208.Tremor Other Hyperkinet Mov (N Y)2014-06-05T00:00:002014In the Gray Zone in the Fragile X Gene: What are the Key Unanswered Clinical and Biological Questions?17618523Berry-Kravis E, Abrams L, Coffey SM, Hall DA, Greco C, Gane LW, Grigsby J, Bourgeois JA, Finucane B, Jacquemont S, Brunberg JA, Zhang L, Lin J, Tassone F, Hagerman PJ, Hagerman RJ, Leehey MAMovement disorders : official journal of the Movement Disorder SocietyFragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines. Mov Disord. 2007 Oct 31; 22(14):2018-30, quiz 2140.Mov Disord2007-10-31T00:00:002007Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines.21778290Schenkman M, Ellis T, Christiansen C, Bar?n AE, Tickle-Degnen L, Hall DA, Wagenaar RPhysical therapyProfile of functional limitations and task performance among people with early- and middle-stage Parkinson disease. Phys Ther. 2011 Sep; 91(9):1339-54.Phys Ther2011-07-21T00:00:002011Profile of functional limitations and task performance among people with early- and middle-stage Parkinson disease.23692864Pretto DI, Hunsaker MR, Cunningham CL, Greco CM, Hagerman RJ, Noctor SC, Hall DA, Hagerman PJ, Tassone FTranslational neurodegenerationIntranuclear inclusions in a fragile X mosaic male. Transl Neurodegener. 2013 May 21; 2(1):10.Transl Neurodegener2013-05-21T00:00:002013Intranuclear inclusions in a fragile X mosaic male.15077252Hall DA, Ringel SPMovement disorders : official journal of the Movement Disorder SocietyAdult nonketotic hyperglycinemia (NKH) crisis presenting as severe chorea and encephalopathy. Mov Disord. 2004 Apr; 19(4):485-6.Mov Disord2004-04-01T00:00:002004Adult nonketotic hyperglycinemia (NKH) crisis presenting as severe chorea and encephalopathy.25852777Hall DA, Birch RC, Anheim M, J?nch AE, Pintado E, O'Keefe JA, Trollor JN, Stebbins GT, Hagerman RJ, Fahn S, Berry-Kravis E, Leehey MAJournal of neurodevelopmental disordersErratum: Emerging topics in FXTAS. J Neurodev Disord. 2015; 7(1):13.J Neurodev Disord2015-04-08T00:00:002015Erratum: Emerging topics in FXTAS.17940108Schenkman M, Hall D, Kumar R, Kohrt WMPhysical therapyEndurance exercise training to improve economy of movement of people with Parkinson disease: three case reports. Phys Ther. 2008 Jan; 88(1):63-76.Phys Ther2007-10-16T00:00:002007Endurance exercise training to improve economy of movement of people with Parkinson disease: three case reports.22161987Hall D, Tassone F, Klepitskaya O, Leehey MMovement disorders : official journal of the Movement Disorder SocietyFragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriers. Mov Disord. 2012 Feb; 27(2):296-300.Mov Disord2011-12-11T00:00:002011Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriers.18686748Hagerman RJ, Hall DA, Coffey S, Leehey M, Bourgeois J, Gould J, Zhang L, Seritan A, Berry-Kravis E, Olichney J, Miller JW, Fong AL, Carpenter R, Bodine C, Gane LW, Rainin E, Hagerman H, Hagerman PJClinical interventions in agingTreatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems. Clin Interv Aging. 2008; 3(2):251-62.Clin Interv Aging2008-01-01T00:00:002008Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems.16773616Hall DA, Berry-Kravis E, Hagerman RJ, Hagerman PJ, Rice CD, Leehey MAMovement disorders : official journal of the Movement Disorder SocietySymptomatic treatment in the fragile X-associated tremor/ataxia syndrome. Mov Disord. 2006 Oct; 21(10):1741-4.Mov Disord2006-10-01T00:00:002006Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome.27250987Hall DA, Haider H, Szczepek AJ, Lau P, Rabau S, Jones-Diette J, Londero A, Edvall NK, Cederroth CR, Mielczarek M, Fuller T, Batuecas-Caletrio A, Brueggemen P, Thompson DM, Norena A, Cima RF, Mehta RL, Mazurek BTrialsSystematic review of outcome domains and instruments used in clinical trials of tinnitus treatments in adults. Trials. 2016 06 01; 17(1):270.Trials2016-06-01T00:00:002016Systematic review of outcome domains and instruments used in clinical trials of tinnitus treatments in adults.21760873Kornak J, Hall DA, Haggard MPThe open neuroimaging journalSpatially extended FMRI signal response to stimulus in non-functionally relevant regions of the human brain: preliminary results. Open Neuroimag J. 2011; 5:24-32.Open Neuroimag J2011-05-11T00:00:002011Spatially extended FMRI signal response to stimulus in non-functionally relevant regions of the human brain: preliminary results.26854325Litvan I, Lees PS, Cunningham CR, Rai SN, Cambon AC, Standaert DG, Marras C, Juncos J, Riley D, Reich S, Hall D, Kluger B, Bordelon Y, Shprecher DRMovement disorders : official journal of the Movement Disorder SocietyEnvironmental and occupational risk factors for progressive supranuclear palsy: Case-control study. Mov Disord. 2016 05; 31(5):644-52.Mov Disord2016-02-08T00:00:002016Environmental and occupational risk factors for progressive supranuclear palsy: Case-control study.23770108Moore CG, Schenkman M, Kohrt WM, Delitto A, Hall DA, Corcos DContemporary clinical trialsStudy in Parkinson disease of exercise (SPARX): translating high-intensity exercise from animals to humans. Contemp Clin Trials. 2013 Sep; 36(1):90-8.Contemp Clin Trials2013-06-14T00:00:002013Study in Parkinson disease of exercise (SPARX): translating high-intensity exercise from animals to humans.26890571Brody DM, Litvan I, Warner S, Riley DE, Hall DA, Kluger BM, Shprecher DR, Cunningham CRMovement disorders : official journal of the Movement Disorder SocietyRelationship between uric acid levels and progressive supranuclear palsy. Mov Disord. 2016 05; 31(5):663-7.Mov Disord2016-02-18T00:00:002016Relationship between uric acid levels and progressive supranuclear palsy.16184602Hessl D, Tassone F, Loesch DZ, Berry-Kravis E, Leehey MA, Gane LW, Barbato I, Rice C, Gould E, Hall DA, Grigsby J, Wegelin JA, Harris S, Lewin F, Weinberg D, Hagerman PJ, Hagerman RJAmerican journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric GeneticsAbnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. Am J Med Genet B Neuropsychiatr Genet. 2005 Nov 05; 139B(1):115-21.Am J Med Genet B Neuropsychiatr Genet2005-11-05T00:00:002005Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation.17651672Hall DA, Sheeder J, Box T, Shroyer ALJournal of investigative medicine : the official publication of the American Federation for Clinical ResearchClinical science training at the University of Colorado: a measurement of trainee satisfaction. J Investig Med. 2007 May; 55(4):181-6.J Investig Med2007-05-01T00:00:002007Clinical science training at the University of Colorado: a measurement of trainee satisfaction.18211155Grigsby J, Brega AG, Engle K, Leehey MA, Hagerman RJ, Tassone F, Hessl D, Hagerman PJ, Cogswell JB, Bennett RE, Cook K, Hall DA, Bounds LS, Paulich MJ, Reynolds ANeuropsychologyCognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome. Neuropsychology. 2008 Jan; 22(1):48-60.Neuropsychology2008-01-01T00:00:002008Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome.26523370Mohamad N, Hoare DJ, Hall DAHearing researchThe consequences of tinnitus and tinnitus severity on cognition: A review of the behavioural evidence. Hear Res. 2016 Feb; 332:199-209.Hear Res2015-10-31T00:00:002015The consequences of tinnitus and tinnitus severity on cognition: A review of the behavioural evidence.18565783Hall DA, Howard K, Hagerman R, Leehey MAParkinsonism & related disordersParkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease. Parkinsonism Relat Disord. 2009 Feb; 15(2):156-9.Parkinsonism Relat Disord2008-06-20T00:00:002008Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease.20702130Hall DA, Jennings D, Seibyl J, Tassone F, Marek KParkinsonism & related disordersFMR1 gene expansion and scans without evidence of dopaminergic deficits in parkinsonism patients. Parkinsonism Relat Disord. 2010 Nov; 16(9):608-11.Parkinsonism Relat Disord2010-08-11T00:00:002010FMR1 gene expansion and scans without evidence of dopaminergic deficits in parkinsonism patients.19705466Tartaglia N, Borodyanskaya M, Borodyanskya M, Hall DAMovement disorders : official journal of the Movement Disorder SocietyTremor in 48,XXYY syndrome. Mov Disord. 2009 Oct 15; 24(13):2001-7.Mov Disord2009-10-15T00:00:002009Tremor in 48,XXYY syndrome.20841969Ortigas MC, Bourgeois JA, Schneider A, Olichney J, Nguyen DV, Cogswell JB, Hall DA, Hagerman RJJournal of clinical psychopharmacologyImproving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine. J Clin Psychopharmacol. 2010 Oct; 30(5):642-4.J Clin Psychopharmacol2010-10-01T00:00:002010Improving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine.21567456Hall DA, Berry-Kravis E, Zhang W, Tassone F, Spector E, Zerbe G, Hagerman PJ, Ouyang B, Leehey MAMovement disorders : official journal of the Movement Disorder SocietyFMR1 gray-zone alleles: association with Parkinson's disease in women? Mov Disord. 2011 Aug 15; 26(10):1900-6.Mov Disord2011-05-12T00:00:002011FMR1 gray-zone alleles: association with Parkinson's disease in women?23842505Hoare DJ, Pierzycki RH, Thomas H, McAlpine D, Hall DATrialsEvaluation of the acoustic coordinated reset (CR?) neuromodulation therapy for tinnitus: study protocol for a double-blind randomized placebo-controlled trial. Trials. 2013 Jul 10; 14:207.Trials2013-07-10T00:00:002013Evaluation of the acoustic coordinated reset (CR?) neuromodulation therapy for tinnitus: study protocol for a double-blind randomized placebo-controlled trial.26298472O'Keefe JA, Robertson-Dick EE, Hall DA, Berry-Kravis ECerebellum (London, England)Gait and Functional Mobility Deficits in Fragile X-Associated Tremor/Ataxia Syndrome. Cerebellum. 2016 08; 15(4):475-82.Cerebellum2016-08-01T00:00:002016Gait and Functional Mobility Deficits in Fragile X-Associated Tremor/Ataxia Syndrome.27372099Debrey SM, Leehey MA, Klepitskaya O, Filley CM, Shah RC, Kluger B, Berry-Kravis E, Spector E, Tassone F, Hall DACerebellum (London, England)Clinical Phenotype of Adult Fragile X Gray Zone Allele Carriers: a Case Series. Cerebellum. 2016 10; 15(5):623-31.Cerebellum2016-10-01T00:00:002016Clinical Phenotype of Adult Fragile X Gray Zone Allele Carriers: a Case Series.25642984Hall DA, Birch RC, Anheim M, J?nch AE, Pintado E, O'Keefe J, Trollor JN, Stebbins GT, Hagerman RJ, Fahn S, Berry-Kravis E, Leehey MAJournal of neurodevelopmental disordersEmerging topics in FXTAS. J Neurodev Disord. 2014; 6(1):31.J Neurodev Disord2014-07-30T00:00:002014Emerging topics in FXTAS.24176424Hall DA, O'Keefe JANeurologic clinicsClinical neurogenetics: fragile x-associated tremor/ataxia syndrome. Neurol Clin. 2013 Nov; 31(4):1073-84.Neurol Clin2013-05-18T00:00:002013Clinical neurogenetics: fragile x-associated tremor/ataxia syndrome.21775737Berry-Kravis E, Hall DANeurologyExecutive dysfunction in young FMR1 premutation carriers: forme fruste of FXTAS or new phenotype? Neurology. 2011 Aug 16; 77(7):612-3.Neurology2011-07-20T00:00:002011Executive dysfunction in young FMR1 premutation carriers: forme fruste of FXTAS or new phenotype?17960815Howard KL, Hall DA, Moon M, Agarwal P, Newman E, Brenner MMovement disorders : official journal of the Movement Disorder SocietyAdult-onset Alexander disease with progressive ataxia and palatal tremor. Mov Disord. 2008 Jan; 23(1):118-22.Mov Disord2008-01-01T00:00:002008Adult-onset Alexander disease with progressive ataxia and palatal tremor.27066582Hall DA, Robertson-Dick EE, O'Keefe JA, Hadd AG, Zhou L, Berry-Kravis ENeurology. GeneticsX-inactivation in the clinical phenotype of fragile X premutation carrier sisters. Neurol Genet. 2016 Feb; 2(1):e45.Neurol Genet2016-02-03T00:00:002016X-inactivation in the clinical phenotype of fragile X premutation carrier sisters.23439567Hall DA, O'keefe JATremor and other hyperkinetic movements (New York, N.Y.)Fragile x-associated tremor ataxia syndrome: the expanding clinical picture, pathophysiology, epidemiology, and update on treatment. Tremor Other Hyperkinet Mov (N Y). 2012; 2.Tremor Other Hyperkinet Mov (N Y)2012-05-11T00:00:002012Fragile x-associated tremor ataxia syndrome: the expanding clinical picture, pathophysiology, epidemiology, and update on treatment.17152065Berry-Kravis E, Goetz CG, Leehey MA, Hagerman RJ, Zhang L, Li L, Nguyen D, Hall DA, Tartaglia N, Cogswell J, Tassone F, Hagerman PJAmerican journal of medical genetics. Part ANeuropathic features in fragile X premutation carriers. Am J Med Genet A. 2007 Jan 01; 143A(1):19-26.Am J Med Genet A2007-01-01T00:00:002007Neuropathic features in fragile X premutation carriers.20568092Hall D, Pickler L, Riley K, Tassone F, Hagerman RMovement disorders : official journal of the Movement Disorder SocietyParkinsonism and cognitive decline in a fragile X mosaic male. Mov Disord. 2010 Jul 30; 25(10):1523-4.Mov Disord2010-07-30T00:00:002010Parkinsonism and cognitive decline in a fragile X mosaic male.17133502Leehey MA, Berry-Kravis E, Min SJ, Hall DA, Rice CD, Zhang L, Grigsby J, Greco CM, Reynolds A, Lara R, Cogswell J, Jacquemont S, Hessl DR, Tassone F, Hagerman R, Hagerman PJMovement disorders : official journal of the Movement Disorder SocietyProgression of tremor and ataxia in male carriers of the FMR1 premutation. Mov Disord. 2007 Jan 15; 22(2):203-6.Mov Disord2007-01-15T00:00:002007Progression of tremor and ataxia in male carriers of the FMR1 premutation.21348791Hall D, Ouyang B, Lonnquist E, Newcombe JThe International journal of neurosciencePragmatic communication is impaired in Parkinson disease. Int J Neurosci. 2011 May; 121(5):254-6.Int J Neurosci2011-02-25T00:00:002011Pragmatic communication is impaired in Parkinson disease.14747503Jacquemont S, Hagerman RJ, Leehey MA, Hall DA, Levine RA, Brunberg JA, Zhang L, Jardini T, Gane LW, Harris SW, Herman K, Grigsby J, Greco CM, Berry-Kravis E, Tassone F, Hagerman PJJAMAPenetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA. 2004 Jan 28; 291(4):460-9.JAMA2004-01-28T00:00:002004Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population.24491663Niu YQ, Yang JC, Hall DA, Leehey MA, Tassone F, Olichney JM, Hagerman RJ, Zhang LParkinsonism & related disordersParkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): revisited. Parkinsonism Relat Disord. 2014 Apr; 20(4):456-9.Parkinsonism Relat Disord2014-01-18T00:00:002014Parkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): revisited.17377923Hall DA, Parsons J, Benke TMovement disorders : official journal of the Movement Disorder SocietyParoxysmal nonkinesigenic dystonia and celiac disease. Mov Disord. 2007 Apr 15; 22(5):708-10.Mov Disord2007-04-15T00:00:002007Paroxysmal nonkinesigenic dystonia and celiac disease.19916856Hall DA, Agarwal P, Griffith A, Segro V, Seeberger LCThe International journal of neuroscienceMovement disorders associated with aripiprazole use: a case series. Int J Neurosci. 2009; 119(12):2274-9.Int J Neurosci2009-01-01T00:00:002009Movement disorders associated with aripiprazole use: a case series.27414076Robertson EE, Hall DA, McAsey AR, O'Keefe JAThe Clinical neuropsychologistFragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders. Clin Neuropsychol. 2016 Aug; 30(6):849-900.Clin Neuropsychol2016-08-01T00:00:002016Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.25368631Fraint A, Vittal P, Szewka A, Bernard B, Berry-Kravis E, Hall DAFrontiers in geneticsNew observations in the fragile X-associated tremor/ataxia syndrome (FXTAS) phenotype. Front Genet. 2014; 5:365.Front Genet2014-10-17T00:00:002014New observations in the fragile X-associated tremor/ataxia syndrome (FXTAS) phenotype.24252602O'Keefe JA, Espinoza Or?as AA, Khan H, Hall DA, Berry-Kravis E, Wimmer MAGait & postureImplementation of a markerless motion analysis method to quantify hyperkinesis in males with fragile X syndrome. Gait Posture. 2014 Feb; 39(2):827-30.Gait Posture2013-10-28T00:00:002013Implementation of a markerless motion analysis method to quantify hyperkinesis in males with fragile X syndrome.27287737Hall DA, Robertson E, Shelton AL, Losh MC, Mila M, Moreno EG, Gomez-Anson B, Mart?nez-Cerde?o V, Grigsby J, Lozano R, Hagerman R, Maria LS, Berry-Kravis E, O'Keefe JACerebellum (London, England)Update on the Clinical, Radiographic, and Neurobehavioral Manifestations in FXTAS and FMR1 Premutation Carriers. Cerebellum. 2016 10; 15(5):578-86.Cerebellum2016-10-01T00:00:002016Update on the Clinical, Radiographic, and Neurobehavioral Manifestations in FXTAS and FMR1 Premutation Carriers.12130436Hulka CA, Hall DA, McCarthy K, Simeone JAJR. American journal of roentgenologySonographic findings in patients with adenomyosis: can sonography assist in predicting extent of disease? AJR Am J Roentgenol. 2002 Aug; 179(2):379-83.AJR Am J Roentgenol2002-08-01T00:00:002002Sonographic findings in patients with adenomyosis: can sonography assist in predicting extent of disease?D014202Disorders281410.87515Tremortrue1Assistant ProfessorAssistant ProfessorBichunOuyangBichun Ouyang349480Ouyang, BichunAssociate ProfessorJoanO'KeefeJoan A. O'Keefe349532O'Keefe, JoanAssociate ProfessorElizabethBerry-KravisElizabeth Berry-Kravis349548Berry-Kravis, ElizabethProfessorRajeevGargRajeev Garg41.87340050000000-87.67011710000000349621Garg, RajeevAssistant ProfessorChristopherGoetzChristopher Goetz349622Goetz, ChristopherProfessorGlennStebbinsGlenn Stebbins349678Stebbins, GlennProfessor6Assistant Professor5Associate Professor4ProfessorAuthorship 38490132053612Hall DA, Robertson EE, Leehey M, McAsey A, Ouyang B, Berry-Kravis E, O'Keefe JAPloS oneOpen-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS). PLoS One. 2020; 15(2):e0225191.PLoS One2020-02-13T00:00:002020Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS).Authorship 386652Authorship 38764232131880Katiri R, Hall DA, Buggy N, Hogan N, Horobin A, van de Heyning P, Firszt JB, Bruce IA, Kitterick PTTrialsCore Rehabilitation Outcome Set for Single Sided Deafness (CROSSSD) study: protocol for an international consensus on outcome measures for single sided deafness interventions using a modified Delphi survey. Trials. 2020 Mar 04; 21(1):238.Trials2020-03-04T00:00:002020Core Rehabilitation Outcome Set for Single Sided Deafness (CROSSSD) study: protocol for an international consensus on outcome measures for single sided deafness interventions using a modified Delphi survey.32183858Katiri R, Hall DA, Buggy N, Hogan N, Horobin A, van de Heyning P, Firszt JB, Bruce IA, Kitterick PTTrialsCorrection to: Core Rehabilitation Outcome Set for Single Sided Deafness (CROSSSD) study: protocol for an international consensus on outcome measures for single sided deafness interventions using a modified Delphi survey. Trials. 2020 03 17; 21(1):272.Trials2020-03-17T00:00:002020Correction to: Core Rehabilitation Outcome Set for Single Sided Deafness (CROSSSD) study: protocol for an international consensus on outcome measures for single sided deafness interventions using a modified Delphi survey.Authorship 38895632258228Hill EJ, Goetz CG, Stebbins GT, Hagerman R, Ouyang B, Hall DAMovement disorders clinical practicePlacebo Response in Fragile X-associated Tremor/Ataxia Syndrome. Mov Disord Clin Pract. 2020 Apr; 7(3):298-302.Mov Disord Clin Pract2020-03-04T00:00:002020Placebo Response in Fragile X-associated Tremor/Ataxia Syndrome.D010300Disorders6311640.510774Parkinson DiseaseAuthorship 393951Authorship 39816332417794Bailey M, Anderson S, Hall DAJournal of Parkinson's diseaseParkinson's Disease in African Americans: A Review of the Current Literature. J Parkinsons Dis. 2020; 10(3):831-841.J Parkinsons Dis2020-01-01T00:00:002020Parkinson's Disease in African Americans: A Review of the Current Literature.32463542Hall DA, Nag S, Ouyang B, Bennett DA, Liu Y, Ali A, Zhou L, Berry-Kravis EMovement disorders : official journal of the Movement Disorder SocietyFragile X Gray Zone Alleles Are Associated With Signs of Parkinsonism and Earlier Death. Mov Disord. 2020 08; 35(8):1448-1456.Mov Disord2020-05-28T00:00:002020Fragile X Gray Zone Alleles Are Associated With Signs of Parkinsonism and Earlier Death.Authorship 40080632731191Rezvanian S, Litvan I, Standaert D, Jankovic J, Reich SG, Hall D, Shprecher DR, Bordelon Y, Dubinsky R, Kluger BParkinsonism & related disordersUnderstanding the relationship between freezing of gait and other progressive supranuclear palsy features. Parkinsonism Relat Disord. 2020 09; 78:56-60.Parkinsonism Relat Disord2020-07-23T00:00:002020Understanding the relationship between freezing of gait and other progressive supranuclear palsy features.Authorship 404209Authorship 4069211Authorship 407326Authorship 4099910Authorship 41457132903267Fleisher JE, Sennott BJ, Myrick E, Niemet CJ, Lee M, Whitelock CM, Sanghvi M, Liu Y, Ouyang B, Hall DA, Comella CL, Chodosh JPloS oneKICK OUT PD: Feasibility and quality of life in the pilot karate intervention to change kinematic outcomes in Parkinson's Disease. PLoS One. 2020; 15(9):e0237777.PLoS One2020-09-09T00:00:002020KICK OUT PD: Feasibility and quality of life in the pilot karate intervention to change kinematic outcomes in Parkinson's Disease.33043077O'Keefe JA, Bang D, Robertson EE, Biskis A, Ouyang B, Liu Y, Pal G, Berry-Kravis E, Hall DAMovement disorders clinical practiceProdromal Markers of Upper Limb Deficits in FMR1 Premutation Carriers and Quantitative Outcome Measures for Future Clinical Trials in Fragile X-associated Tremor/Ataxia Syndrome. Mov Disord Clin Pract. 2020 Oct; 7(7):810-819.Mov Disord Clin Pract2020-08-29T00:00:002020Prodromal Markers of Upper Limb Deficits in FMR1 Premutation Carriers and Quantitative Outcome Measures for Future Clinical Trials in Fragile X-associated Tremor/Ataxia Syndrome.33110011Hall DA, Leehey MA, Hagerman RJ, Pelak VSJournal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology SocietyEye Movements in Fragile X-Associated Tremor/Ataxia Syndrome. J Neuroophthalmol. 2021 12 01; 41(4):e661-e664.J Neuroophthalmol2021-12-01T00:00:002021Eye Movements in Fragile X-Associated Tremor/Ataxia Syndrome.33118140O'Keefe JA, Guan J, Robertson E, Biskis A, Joyce J, Ouyang B, Liu Y, Carnes D, Purcell N, Berry-Kravis E, Hall DACerebellum (London, England)The Effects of Dual Task Cognitive Interference and Fast-Paced Walking on Gait, Turns, and Falls in Men and Women with FXTAS. Cerebellum. 2021 Apr; 20(2):212-221.Cerebellum2020-10-28T00:00:002020The Effects of Dual Task Cognitive Interference and Fast-Paced Walking on Gait, Turns, and Falls in Men and Women with FXTAS.33341562Garg RK, Ouyang B, Khan J, Panos N, Da Silva I, Hall D, Shepherd S, John S, Kocak M, Bhabad S, Kazlauskaite R, Jhaveri M, Bleck TPJournal of stroke and cerebrovascular diseases : the official journal of National Stroke AssociationAssociation of Longitudinal Glycemia with Diffusion Weighted Imaging Lesions in Spontaneous Intracerebral Hemorrhage. J Stroke Cerebrovasc Dis. 2021 Mar; 30(3):105554.J Stroke Cerebrovasc Dis2020-12-18T00:00:002020Association of Longitudinal Glycemia with Diffusion Weighted Imaging Lesions in Spontaneous Intracerebral Hemorrhage.Neurological SciencesOrthopedic SurgeryAnatomy and Cell BiologyRush University, Rush Medical CollegeMichaelLiptayMichael Liptay41.87340050000000-87.67011710000000349003Liptay, MichaelProfessorDavidBennettDavid A. Bennett41.87328300000000-87.66936330000000349004Bennett, DavidProfessorJeffreyKordowerJeffrey Kordower41.87386750000000-87.67102690000000349008Kordower, JeffreyProfessorAliKeshavarzianAli Keshavarzian41.87386750000000-87.67102690000000349021Keshavarzian, AliProfessorAuthorship 417196Authorship 417599Authorship 418105Authorship 418242Authorship 418623Authorship 418829Authorship 4194116Authorship 421009Authorship 423793Authorship 42477233553488Patel RA, Hall DA, Eichenseer S, Bailey MMovement disorders clinical practiceMovement Disorders and Hematologic Diseases. Mov Disord Clin Pract. 2021 Feb; 8(2):193-207.Mov Disord Clin Pract2020-12-29T00:00:002020Movement Disorders and Hematologic Diseases.33631006Bailey M, Shulman LM, Ryan D, Ouyang B, Shulman JM, Buchman AS, Bennett DA, Barnes LL, Hall DAThe journals of gerontology. Series A, Biological sciences and medical sciencesFrequency of Parkinsonism and Parkinson Disease in African Americans in the Chicago Community. J Gerontol A Biol Sci Med Sci. 2021 06 14; 76(7):1340-1345.J Gerontol A Biol Sci Med Sci2021-06-14T00:00:002021Frequency of Parkinsonism and Parkinson Disease in African Americans in the Chicago Community.33638050Witek N, Hawkins J, Hall DCurrent neurology and neuroscience reportsGenetic ataxias: update on classification and diagnostic approaches. Curr Neurol Neurosci Rep. 2021 02 26; 21(3):13.Curr Neurol Neurosci Rep2021-02-26T00:00:002021Genetic ataxias: update on classification and diagnostic approaches.33743802Katiri R, Hall DA, Killan CF, Smith S, Prayuenyong P, Kitterick PTTrialsSystematic review of outcome domains and instruments used in designs of clinical trials for interventions that seek to restore bilateral and binaural hearing in adults with unilateral severe to profound sensorineural hearing loss ('single-sided deafness'). Trials. 2021 Mar 20; 22(1):220.Trials2021-03-20T00:00:002021Systematic review of outcome domains and instruments used in designs of clinical trials for interventions that seek to restore bilateral and binaural hearing in adults with unilateral severe to profound sensorineural hearing loss ('single-sided deafness').33752094Royhman D, Pourzal R, Hall D, Lundberg HJ, Wimmer MA, Jacobs J, Hallab NJ, Mathew MTJournal of the mechanical behavior of biomedical materialsFretting-corrosion in hip taper modular junctions: The influence of topography and pH levels - An in-vitro study. J Mech Behav Biomed Mater. 2021 06; 118:104443.J Mech Behav Biomed Mater2021-03-12T00:00:002021Fretting-corrosion in hip taper modular junctions: The influence of topography and pH levels - An in-vitro study.33838500Garg RK, Alberawi M, Ouyang B, John S, Silva ID, Shepherd S, Kocak M, Bhabad S, Hall DA, Jhaveri MD, Bleck TPJournal of the neurological sciencesTiming of diffusion weighted imaging lesions in spontaneous intracerebral hemorrhage. J Neurol Sci. 2021 06 15; 425:117434.J Neurol Sci2021-04-03T00:00:002021Timing of diffusion weighted imaging lesions in spontaneous intracerebral hemorrhage.33897612Litvan I, Proudfoot JA, Martin ER, Standaert D, Riley D, Hall D, Marras C, Bayram E, Dubinsky RM, Bordelon Y, Reich S, Shprecher D, Kluger B, Cunningham C, Schellenberg GD, Jankovic JFrontiers in neurologyGene-Environment Interactions in Progressive Supranuclear Palsy. Front Neurol. 2021; 12:664796.Front Neurol2021-04-09T00:00:002021Gene-Environment Interactions in Progressive Supranuclear Palsy.33968470Witek N, Afshari M, Liu Y, Ouyang B, Hall DNeurology. Clinical practiceInpatient vs Outpatient Evaluation of Suspected Paraneoplastic Cerebellar Degeneration. Neurol Clin Pract. 2021 Feb; 11(1):33-42.Neurol Clin Pract2021-02-01T00:00:002021Inpatient vs Outpatient Evaluation of Suspected Paraneoplastic Cerebellar Degeneration.34016428Trevino CE, Rounds JC, Charen K, Shubeck L, Hipp HS, Spencer JB, Johnston HR, Cutler DJ, Zwick ME, Epstein MP, Murray A, Macpherson JN, Mila M, Rodriguez-Revenga L, Berry-Kravis E, Hall DA, Leehey MA, Liu Y, Welt C, Warren ST, Sherman SL, Jin P, Allen EGFertility and sterilityIdentifying susceptibility genes for primary ovarian insufficiency on the high-risk genetic background of a fragile X premutation. Fertil Steril. 2021 09; 116(3):843-854.Fertil Steril2021-05-18T00:00:002021Identifying susceptibility genes for primary ovarian insufficiency on the high-risk genetic background of a fragile X premutation.34046842Abbasi DA, Nguyen TTA, Hall DA, Robertson-Dick E, Berry-Kravis E, Cologna SMCerebellum (London, England)Characterization of the Cerebrospinal Fluid Proteome in Patients with Fragile X-Associated Tremor/Ataxia Syndrome. Cerebellum. 2022 Feb; 21(1):86-98.Cerebellum2021-05-27T00:00:002021Characterization of the Cerebrospinal Fluid Proteome in Patients with Fragile X-Associated Tremor/Ataxia Syndrome.34117786Mailick MR, Hong J, Movaghar A, DaWalt L, Berry-Kravis EM, Brilliant MH, Boero J, Todd PK, Hall DMovement disorders : official journal of the Movement Disorder SocietyMild Neurological Signs in FMR1 Premutation Women in an Unselected Community-Based Cohort. Mov Disord. 2021 10; 36(10):2378-2386.Mov Disord2021-06-12T00:00:002021Mild Neurological Signs in FMR1 Premutation Women in an Unselected Community-Based Cohort.Authorship 429936Authorship 4316411Authorship 4323713Authorship 435392Authorship 43555334238753Fleisher JE, Hess S, Sennott BJ, Myrick E, Wallace EK, Lee J, Sanghvi M, Woo K, Ouyang B, Wilkinson JR, Beck J, Johnson TJ, Hall DA, Chodosh JJMIR research protocolsLongitudinal, Interdisciplinary Home Visits Versus Usual Care for Homebound People With Advanced Parkinson Disease: Protocol for a Controlled Trial. JMIR Res Protoc. 2021 Sep 14; 10(9):e31690.JMIR Res Protoc2021-09-14T00:00:002021Longitudinal, Interdisciplinary Home Visits Versus Usual Care for Homebound People With Advanced Parkinson Disease: Protocol for a Controlled Trial.34276285Manfready RA, Engen PA, Verhagen Metman L, Sanzo G, Goetz CG, Hall DA, Forsyth CB, Raeisi S, Voigt RM, Keshavarzian AFrontiers in neuroscienceAttenuated Postprandial GLP-1 Response in Parkinson's Disease. Front Neurosci. 2021; 15:660942.Front Neurosci2021-07-02T00:00:002021Attenuated Postprandial GLP-1 Response in Parkinson's Disease.34316626Robertson EE, Hall DA, Pal G, Ouyang B, Liu Y, Joyce JM, Berry-Kravis E, O'Keefe JAClinical parkinsonism & related disordersTremorography in fragile X-associated tremor/ataxia syndrome, Parkinson's disease and essential tremor. Clin Park Relat Disord. 2020; 3:100040.Clin Park Relat Disord2020-01-23T00:00:002020Tremorography in fragile X-associated tremor/ataxia syndrome, Parkinson's disease and essential tremor.34421690Maltman N, Guilfoyle J, Nayar K, Martin GE, Winston M, Lau JCY, Bush L, Patel S, Lee M, Sideris J, Hall DA, Zhou L, Sharp K, Berry-Kravis E, Losh MFrontiers in psychiatryThe Phenotypic Profile Associated With the FMR1 Premutation in Women: An Investigation of Clinical-Behavioral, Social-Cognitive, and Executive Abilities. Front Psychiatry. 2021; 12:718485.Front Psychiatry2021-08-06T00:00:002021The Phenotypic Profile Associated With the FMR1 Premutation in Women: An Investigation of Clinical-Behavioral, Social-Cognitive, and Executive Abilities.34505966Abbasi DA, Nguyen TTA, Hall DA, Robertson-Dick E, Berry-Kravis E, Cologna SMCerebellum (London, England)Correction to: Characterization of the Cerebrospinal Fluid Proteome in Patients with Fragile X-Associated Tremor/Ataxia Syndrome. Cerebellum. 2022 Feb; 21(1):99-100.Cerebellum2022-02-01T00:00:002022Correction to: Characterization of the Cerebrospinal Fluid Proteome in Patients with Fragile X-Associated Tremor/Ataxia Syndrome.true1Associate ProfessorAssociate ProfessorAuthorship 4356919Authorship 4361218Authorship 4371611Authorship 438227Authorship 438537Authorship 439582Authorship 442025Authorship 442074Authorship 444297Authorship 447153Authorship 4481729Authorship 4501210Authorship 451901Authorship 45227534631945Tosin MHS, Stebbins GT, Comella C, Patterson CG, Hall DAMovement disorders clinical practiceDoes MDS-UPDRS Provide Greater Sensitivity to Mild Disease than UPDRS in De Novo Parkinson's Disease? Mov Disord Clin Pract. 2021 Oct; 8(7):1092-1099.Mov Disord Clin Pract2021-09-06T00:00:002021Does MDS-UPDRS Provide Greater Sensitivity to Mild Disease than UPDRS in De Novo Parkinson's Disease?34992953Kapur S, Vaughan C, Hawkins J, Stebbins G, Hall DNeurology. Clinical practiceVarenicline for the Treatment of Postural and Gait Dysfunction in Parkinson Disease. Neurol Clin Pract. 2021 Dec; 11(6):457-461.Neurol Clin Pract2021-12-01T00:00:002021Varenicline for the Treatment of Postural and Gait Dysfunction in Parkinson Disease.34782410Pringsheim T, Day GS, Smith DB, Rae-Grant A, Licking N, Armstrong MJ, de Bie RMA, Roze E, Miyasaki JM, Hauser RA, Espay AJ, Martello JP, Gurwell JA, Billinghurst L, Sullivan K, Fitts MS, Cothros N, Hall DA, Rafferty M, Hagerbrant L, Hastings T, O'Brien MD, Silsbee H, Gronseth G, Lang AENeurologyDopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee. Neurology. 2021 11 16; 97(20):942-957.Neurology2021-11-16T00:00:002021Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee.34984729Pal G, Mangone G, Hill EJ, Ouyang B, Liu Y, Lythe V, Ehrlich D, Saunders-Pullman R, Shanker V, Bressman S, Alcalay RN, Garcia P, Marder KS, Aasly J, Mouradian MM, Link S, Rosenbaum M, Anderson S, Bernard B, Wilson R, Stebbins G, Nichols WC, Welter ML, Sani S, Afshari M, Verhagen L, de Bie RMA, Foltynie T, Hall D, Corvol JC, Goetz CGAnnals of neurologyParkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers. Ann Neurol. 2022 03; 91(3):424-435.Ann Neurol2022-01-25T00:00:002022Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers.35123318Bailey M, Anderson S, Stebbins G, Barnes L, Shulman LM, Tartakovsky J, Hall DAParkinsonism & related disordersComparison of motor, non-motor, and quality of life phenotype in Black and White patients with Parkinson's disease. Parkinsonism Relat Disord. 2022 03; 96:18-21.Parkinsonism Relat Disord2022-01-22T00:00:002022Comparison of motor, non-motor, and quality of life phenotype in Black and White patients with Parkinson's disease.35136703Cooper CS, Hall DATremor and other hyperkinetic movements (New York, N.Y.)Advance Directive Documentation in a Huntington's Disease Clinic: A Retrospective Chart Review. Tremor Other Hyperkinet Mov (N Y). 2022; 12:4.Tremor Other Hyperkinet Mov (N Y)2022-02-01T00:00:002022Advance Directive Documentation in a Huntington's Disease Clinic: A Retrospective Chart Review.35137065Zhang Y, Glineburg MR, Basrur V, Conlon K, Wright SE, Krans A, Hall DA, Todd PKHuman molecular geneticsMechanistic convergence across initiation sites for RAN translation in fragile X associated tremor ataxia syndrome. Hum Mol Genet. 2022 07 21; 31(14):2317-2332.Hum Mol Genet2022-07-21T00:00:002022Mechanistic convergence across initiation sites for RAN translation in fragile X associated tremor ataxia syndrome.35260334Hall DParkinsonism & related disordersParkinson's disease: Let food be thy medicine and medicine be thy food (Hippocrates). Parkinsonism Relat Disord. 2022 02; 95:113-114.Parkinsonism Relat Disord2021-12-16T00:00:002021Parkinson's disease: Let food be thy medicine and medicine be thy food (Hippocrates).35481819Fleisher JE, Akram F, Lee J, Klostermann EC, Hess SP, Myrick E, Levin M, Ouyang B, Wilkinson J, Hall DA, Chodosh JJMIR research protocolsPeer Mentoring Program for Informal Caregivers of Homebound Individuals With Advanced Parkinson Disease (Share the Care): Protocol for a Single-Center, Crossover Pilot Study. JMIR Res Protoc. 2022 May 26; 11(5):e34750.JMIR Res Protoc2022-05-26T00:00:002022Peer Mentoring Program for Informal Caregivers of Homebound Individuals With Advanced Parkinson Disease (Share the Care): Protocol for a Single-Center, Crossover Pilot Study.35633466Manfready RA, Forsyth CB, Voigt RM, Hall DA, Goetz CG, Keshavarzian ACurrent neurology and neuroscience reportsGut-Brain Communication in Parkinson's Disease: Enteroendocrine Regulation by GLP-1. Curr Neurol Neurosci Rep. 2022 07; 22(7):335-342.Curr Neurol Neurosci Rep2022-05-28T00:00:002022Gut-Brain Communication in Parkinson's Disease: Enteroendocrine Regulation by GLP-1.35654277Voigt RM, Wang Z, Brown JM, Engen PA, Naqib A, Goetz CG, Hall DA, Metman LV, Shaikh M, Forsyth CB, Keshavarzian ANeurobiology of diseaseGut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status. Neurobiol Dis. 2022 08; 170:105780.Neurobiol Dis2022-05-30T00:00:002022Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status.35687082Pal G, Mangone G, Ouyang B, Ehrlich D, Saunders-Pullman R, Bressman S, Alcalay RN, Marder K, Aasly J, Mouradian MM, Anderson S, Bernard B, Stebbins G, Sani S, Afshari M, Verhagen L, de Bie RMA, Foltynie T, Hall D, Corvol JC, Goetz CGAnnals of neurologyReply to: Cognitive Effects of Deep Brain Stimulation in GBA-Related Parkinson's Disease. Ann Neurol. 2022 08; 92(2):345-346.Ann Neurol2022-06-30T00:00:002022Reply to: Cognitive Effects of Deep Brain Stimulation in GBA-Related Parkinson's Disease.35701103Hessl D, Rosselot H, Miller R, Espinal G, Famula J, Sherman SL, Todd PK, Cabal Herrera AM, Lipworth K, Cohen J, Hall DA, Leehey M, Grigsby J, Weber JD, Alusi S, Wheeler A, Raspa M, Hudson T, Sobrian SKJournal of medical geneticsThe International Fragile X Premutation Registry: building a resource for research and clinical trial readiness. J Med Genet. 2022 12; 59(12):1165-1170.J Med Genet2022-06-14T00:00:002022The International Fragile X Premutation Registry: building a resource for research and clinical trial readiness.Authorship 45570735780693Joyce J, Cabanas N, Pisharody R, Ouyang B, Patel R, Reiser J, Hall DA, Witek NParkinsonism & related disordersSoluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism. Parkinsonism Relat Disord. 2022 08; 101:39-42.Parkinsonism Relat Disord2022-06-28T00:00:002022Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism.Cardiovascular and Thoracic SurgeryInternal Medicine, Division of Digestive Diseases and Nutritiontrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessorAuthorship 259202Authorship 260386Authorship 263117Authorship 263368Authorship 266728Authorship 26727227709117Pal GD, Hall D, Ouyang B, Phelps J, Alcalay R, Pauciulo MW, Nichols WC, Clark L, Mejia-Santana H, Blasucci L, Goetz CG, Comella C, Colcher A, Gan-Or Z, Rouleau GA, Marder KMovement disorders clinical practiceGenetic and Clinical Predictors of Deep Brain Stimulation in Young-Onset Parkinson's Disease. Mov Disord Clin Pract. 2016 Sep-Oct; 3(5):465-471.Mov Disord Clin Pract2016-01-18T00:00:002016Genetic and Clinical Predictors of Deep Brain Stimulation in Young-Onset Parkinson's Disease.27793167Pal G, O'Keefe J, Robertson-Dick E, Bernard B, Anderson S, Hall DJournal of neuroengineering and rehabilitationGlobal cognitive function and processing speed are associated with gait and balance dysfunction in Parkinson's disease. J Neuroeng Rehabil. 2016 10 28; 13(1):94.J Neuroeng Rehabil2016-10-28T00:00:002016Global cognitive function and processing speed are associated with gait and balance dysfunction in Parkinson's disease.27980694Hadd AG, Filipovic-Sadic S, Zhou L, Williams A, Latham GJ, Berry-Kravis E, Hall DAClinical epigeneticsA methylation PCR method determines FMR1 activation ratios and differentiates premutation allele mosaicism in carrier siblings. Clin Epigenetics. 2016; 8:130.Clin Epigenetics2016-12-01T00:00:002016A methylation PCR method determines FMR1 activation ratios and differentiates premutation allele mosaicism in carrier siblings.28007518Bluett B, Litvan I, Cheng S, Juncos J, Riley DE, Standaert DG, Reich SG, Hall DA, Kluger B, Shprecher D, Marras C, Jankovic JParkinsonism & related disordersUnderstanding falls in progressive supranuclear palsy. Parkinsonism Relat Disord. 2017 02; 35:75-81.Parkinsonism Relat Disord2016-12-15T00:00:002016Understanding falls in progressive supranuclear palsy.28263256Christiansen C, Moore C, Schenkman M, Kluger B, Kohrt W, Delitto A, Berman B, Hall D, Josbeno D, Poon C, Robichaud J, Wellington T, Jain S, Comella C, Corcos D, Melanson EJournal of neurologic physical therapy : JNPTFactors Associated With Ambulatory Activity in De Novo Parkinson Disease. J Neurol Phys Ther. 2017 Apr; 41(2):93-100.J Neurol Phys Ther2017-04-01T00:00:002017Factors Associated With Ambulatory Activity in De Novo Parkinson Disease.28291595Kaub-Wittemer D, Hall DA, Kumpf U, Padberg F, Schneider SAParkinsonism & related disordersFragile X-associated tremor ataxia syndrome presenting as chronic fatigue syndrome. Parkinsonism Relat Disord. 2017 06; 39:85-86.Parkinsonism Relat Disord2017-03-07T00:00:002017Fragile X-associated tremor ataxia syndrome presenting as chronic fatigue syndrome.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessorJeffreyHausdorffJeffrey Hausdorff350010Hausdorff, JeffreyProfessorD051860Chemicals & Drugs111170.915775Fragile X Mental Retardation ProteinAuthorship 458365Authorship 463644Authorship 463521Authorship 457529Authorship 457052Authorship 467184Authorship 472461Authorship 4772315Authorship 4674215Authorship 483744Authorship 470464Authorship 4707815Authorship 480521Authorship 4784915Authorship 474711436076299Katiri R, Hall DA, Hoare DJ, Fackrell K, Horobin A, Hogan N, Buggy N, Van de Heyning PH, Firszt JB, Bruce IA, Kitterick PTTrialsThe Core Rehabilitation Outcome Set for Single-Sided Deafness (CROSSSD) study: International consensus on outcome measures for trials of interventions for adults with single-sided deafness. Trials. 2022 Sep 08; 23(1):764.Trials2022-09-08T00:00:002022The Core Rehabilitation Outcome Set for Single-Sided Deafness (CROSSSD) study: International consensus on outcome measures for trials of interventions for adults with single-sided deafness.36446676Fleisher JE, Suresh M, Klostermann EC, Lee J, Hess SP, Myrick E, Mitchem D, Woo K, Sennott BJ, Witek NP, Chen SM, Beck JC, Ouyang B, Wilkinson JR, Hall DA, Chodosh JParkinsonism & related disordersIN-HOME-PDCaregivers: The effects of a combined home visit and peer mentoring intervention for caregivers of homebound individuals with advanced Parkinson's disease. Parkinsonism Relat Disord. 2023 01; 106:105222.Parkinsonism Relat Disord2022-11-17T00:00:002022IN-HOME-PDCaregivers: The effects of a combined home visit and peer mentoring intervention for caregivers of homebound individuals with advanced Parkinson's disease.37398408Rizig M, Bandres-Ciga S, Makarious MB, Ojo O, Crea PW, Abiodun O, Levine KS, Abubakar S, Achoru C, Vitale D, Adeniji O, Agabi O, Koretsky MJ, Agulanna U, Hall DA, Akinyemi R, Xie T, Ali M, Shamim EA, Ani-Osheku I, Padmanaban M, Arigbodi O, Standaert DG, Bello A, Dean M, Erameh C, Elsayed I, Farombi T, Okunoye O, Fawale M, Billingsley KJ, Imarhiagbe F, Jerez PA, Iwuozo E, Baker B, Komolafe M, Malik L, Nwani P, Daida K, Nwazor E, Miano-Burkhardt A, Nyandaiti Y, Fang ZH, Obiabo Y, Kluss JH, Odeniyi O, Hernandez D, Odiase F, Tayebi N, Ojini F, Sidranksy E, Onwuegbuzie G, D'Souza AM, Osaigbovo G, Berhe B, Osemwegie N, Reed X, Oshinaike O, Leonard H, Otubogun F, Alvarado CX, Oyakhire S, Ozomma S, Samuel S, Taiwo F, Wahab K, Zubair Y, Iwaki H, Kim JJ, Morris HR, Hardy J, Nalls M, Heilbron K, Norcliffe-Kaufmann LmedRxiv : the preprint server for health sciencesGenome-wide Association Identifies Novel Etiological Insights Associated with Parkinson's Disease in African and African Admixed Populations. medRxiv. 2023 May 07.medRxiv2023-05-07T00:00:002023Genome-wide Association Identifies Novel Etiological Insights Associated with Parkinson's Disease in African and African Admixed Populations.36539777Labree B, Hoare DJ, Fackrell K, Hall DA, Gascoyne LE, Sereda MTrialsEstablishing a Core Domain Set for early-phase clinical trials of electrical stimulation interventions for tinnitus in adults: protocol for an online Delphi study. Trials. 2022 Dec 21; 23(1):1039.Trials2022-12-21T00:00:002022Establishing a Core Domain Set for early-phase clinical trials of electrical stimulation interventions for tinnitus in adults: protocol for an online Delphi study.36540155Olvera C, Stebbins GT, Romero VP, Hall DANeurology. Clinical practiceCriminality in Huntington Disease. Neurol Clin Pract. 2022 Dec; 12(6):397-405.Neurol Clin Pract2022-12-01T00:00:002022Criminality in Huntington Disease.35844280Thordarson D, Silva J, Ouyang B, Bernard B, Hall DMovement disorders clinical practiceQuality of Life in Fragile X-Associated Tremor/Ataxia Syndrome. Mov Disord Clin Pract. 2022 Jul; 9(5):710-711.Mov Disord Clin Pract2022-04-22T00:00:002022Quality of Life in Fragile X-Associated Tremor/Ataxia Syndrome.36691982Boktor JC, Sharon G, Verhagen Metman LA, Hall DA, Engen PA, Zreloff Z, Hakim DJ, Bostick JW, Ousey J, Lange D, Humphrey G, Ackermann G, Carlin M, Knight R, Keshavarzian A, Mazmanian SKMovement disorders : official journal of the Movement Disorder SocietyIntegrated Multi-Cohort Analysis of the Parkinson's Disease Gut Metagenome. Mov Disord. 2023 03; 38(3):399-409.Mov Disord2023-01-24T00:00:002023Integrated Multi-Cohort Analysis of the Parkinson's Disease Gut Metagenome.36188408Tosin MHS, Stebbins GT, Goetz CG, Hagerman RJ, Hessl D, Zolecki MA, Todd PK, Leehey MA, Hall DAFrontiers in neurologyFragile X-associated tremor ataxia syndrome rating scale: Revision and content validity using a mixed method approach. Front Neurol. 2022; 13:977380.Front Neurol2022-09-14T00:00:002022Fragile X-associated tremor ataxia syndrome rating scale: Revision and content validity using a mixed method approach.36270897Hall DA, Cahill C, Meyer AL, Peltier A, Dy-Hollins M, Goldman MNeurologyGender Disparities in the Career of Neurology Researchers. Neurology. 2023 01 31; 100(5):e454-e464.Neurology2022-10-21T00:00:002022Gender Disparities in the Career of Neurology Researchers.36801916Hall DA, Voigt RM, Cantu-Jungles TM, Hamaker B, Engen PA, Shaikh M, Raeisi S, Green SJ, Naqib A, Forsyth CB, Chen T, Manfready R, Ouyang B, Rasmussen HE, Sedghi S, Goetz CG, Keshavarzian ANature communicationsAn open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson's disease participants. Nat Commun. 2023 02 18; 14(1):926.Nat Commun2023-02-18T00:00:002023An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson's disease participants.37633302Rizig M, Bandres-Ciga S, Makarious MB, Ojo OO, Crea PW, Abiodun OV, Levine KS, Abubakar SA, Achoru CO, Vitale D, Adeniji OA, Agabi OP, Koretsky MJ, Agulanna U, Hall DA, Akinyemi RO, Xie T, Ali MW, Shamim EA, Ani-Osheku I, Padmanaban M, Arigbodi OM, Standaert DG, Bello AH, Dean MN, Erameh CO, Elsayed I, Farombi TH, Okunoye O, Fawale MB, Billingsley KJ, Imarhiagbe FA, Jerez PA, Iwuozo EU, Baker B, Komolafe MA, Malik L, Nwani PO, Daida K, Nwazor EO, Miano-Burkhardt A, Nyandaiti YW, Fang ZH, Obiabo YO, Kluss JH, Odeniyi OA, Hernandez DG, Odiase FE, Tayebi N, Ojini FI, Sidranksy E, Onwuegbuzie GA, D'Souza AM, Osaigbovo GO, Berhe B, Osemwegie N, Reed X, Oshinaike OO, Leonard HL, Otubogun FM, Alvarado CX, Oyakhire SI, Ozomma SI, Samuel SC, Taiwo FT, Wahab KW, Zubair YA, Iwaki H, Kim JJ, Morris HR, Hardy J, Nalls MA, Heilbron K, Norcliffe-Kaufmann LThe Lancet. NeurologyIdentification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study. Lancet Neurol. 2023 11; 22(11):1015-1025.Lancet Neurol2023-08-23T00:00:002023Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study.37081740Martino D, Karnik V, Bhidayasiri R, Hall DA, Hauser RA, Macerollo A, Pringsheim TM, Truong D, Factor SA, Skorvanek M, Schrag AMovement disorders : official journal of the Movement Disorder SocietyScales for Antipsychotic-Associated Movement Disorders: Systematic Review, Critique, and Recommendations. Mov Disord. 2023 06; 38(6):1008-1026.Mov Disord2023-04-20T00:00:002023Scales for Antipsychotic-Associated Movement Disorders: Systematic Review, Critique, and Recommendations.35963046Fleisher JE, Hess SP, Klostermann EC, Lee J, Myrick E, Mitchem D, Niemet C, Woo K, Sennott BJ, Sanghvi M, Witek N, Beck JC, Wilkinson JR, Ouyang B, Hall DA, Chodosh JParkinsonism & related disordersIN-HOME-PD: The effects of longitudinal telehealth-enhanced interdisciplinary home visits on care and quality of life for homebound individuals with Parkinson's disease. Parkinsonism Relat Disord. 2022 09; 102:68-76.Parkinsonism Relat Disord2022-08-07T00:00:002022IN-HOME-PD: The effects of longitudinal telehealth-enhanced interdisciplinary home visits on care and quality of life for homebound individuals with Parkinson's disease.37759552Tassone F, Protic D, Allen EG, Archibald AD, Baud A, Brown TW, Budimirovic DB, Cohen J, Dufour B, Eiges R, Elvassore N, Gabis LV, Grudzien SJ, Hall DA, Hessl D, Hogan A, Hunter JE, Jin P, Jiraanont P, Klusek J, Kooy RF, Kraan CM, Laterza C, Lee A, Lipworth K, Losh M, Loesch D, Lozano R, Mailick MR, Manolopoulos A, Martinez-Cerdeno V, McLennan Y, Miller RM, Montanaro FAM, Mosconi MW, Potter SN, Raspa M, Rivera SM, Shelly K, Todd PK, Tutak K, Wang JY, Wheeler A, Winarni TI, Zafarullah M, Hagerman RJCellsInsight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation. Cells. 2023 09 21; 12(18).Cells2023-09-21T00:00:002023Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation.37778884Hall DParkinsonism & related disordersDevice-aided therapies for Parkinson's disease: "All for one, one for all, that is our device". Parkinsonism Relat Disord. 2023 Nov; 116:105862.Parkinsonism Relat Disord2023-09-19T00:00:002023Device-aided therapies for Parkinson's disease: "All for one, one for all, that is our device".29325626Hall DA, Berry-Kravis EHandbook of clinical neurologyFragile X syndrome and fragile X-associated tremor ataxia syndrome. Handb Clin Neurol. 2018; 147:377-391.Handb Clin Neurol2018-01-01T00:00:002018Fragile X syndrome and fragile X-associated tremor ataxia syndrome.Authorship 299164Authorship 300649Authorship 30104129228079Schenkman M, Moore CG, Kohrt WM, Hall DA, Delitto A, Comella CL, Josbeno DA, Christiansen CL, Berman BD, Kluger BM, Melanson EL, Jain S, Robichaud JA, Poon C, Corcos DMJAMA neurologyEffect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial. JAMA Neurol. 2018 02 01; 75(2):219-226.JAMA Neurol2018-02-01T00:00:002018Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial.29307562Marras C, Cunningham CR, Hou J, Proudfoot J, Standaert DG, Juncos J, Riley D, Reich SG, Hall D, Kluger B, Bordelon Y, Shprecher DR, Litvan IParkinsonism & related disordersAnti-inflammatory drug use and progressive supranuclear palsy. Parkinsonism Relat Disord. 2018 03; 48:89-92.Parkinsonism Relat Disord2017-12-06T00:00:002017Anti-inflammatory drug use and progressive supranuclear palsy.Authorship 306881029460982Park HK, Ilango S, Charriez CM, Checkoway H, Riley D, Standaert DG, Bordelon Y, Shprecher DR, Reich SG, Hall D, Kluger B, Marras C, Jankovic J, Dubinsky R, Litvan IMovement disorders : official journal of the Movement Disorder SocietyLifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study. Mov Disord. 2018 03; 33(3):468-472.Mov Disord2018-02-20T00:00:002018Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study.Authorship 48889738162443Robertson-Dick EE, Timm EC, Pal G, Ouyang B, Liu Y, Berry-Kravis E, Hall DA, O'Keefe JAFrontiers in neurologyDigital gait markers to potentially distinguish fragile X-associated tremor/ataxia syndrome, Parkinson's disease, and essential tremor. Front Neurol. 2023; 14:1308698.Front Neurol2023-12-07T00:00:002023Digital gait markers to potentially distinguish fragile X-associated tremor/ataxia syndrome, Parkinson's disease, and essential tremor.true1ProfessorProfessortrue1Associate ProfessorAssociate ProfessorAuthorship 31504129549220Hall DA, Ramos AR, Gelfand JM, Videnovic A, Benatar M, Cahill C, Kluger BM, Goldman MNeurologyThe state of clinical research in neurology. Neurology. 2018 04 10; 90(15):e1347-e1354.Neurology2018-03-16T00:00:002018The state of clinical research in neurology.Authorship 322501Authorship 32397129887875Hall DA, Fraint A, Dafer RFrontiers in geneticsAcute Stroke in Middle Cerebellar Peduncle in a Patient With FXTAS. Front Genet. 2018; 9:187.Front Genet2018-05-25T00:00:002018Acute Stroke in Middle Cerebellar Peduncle in a Patient With FXTAS.29951081Hall DA, Hagerman RJFrontiers in geneticsFragile X-Associated Tremor/Ataxia Syndrome: Unmet Needs and a Path for the Future. Front Genet. 2018; 9:100.Front Genet2018-06-07T00:00:002018Fragile X-Associated Tremor/Ataxia Syndrome: Unmet Needs and a Path for the Future.